TP53 and ovarian carcinoma: The cumulative DNA damage resulting from ROS exposure increases the risk of mutations in oncogenes or tumor suppressor genes, such as KRAS, BRCA1, BRCA2, and TP53, all of which are frequently altered in ovarian cancer [118].